Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy

Author：

Publisher： Spandidos Publications

ISSN： 1792-0981

Source： Experimental and Therapeutic Medicine, Vol.6, Iss.1, 2013-01, pp. : 109-114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical outcome in diffuse large B-cell lymphoma with hepatitis C virus infection in the rituximab era: A single center experience

By Nishikawa Hiroki Tsudo Mitsuru Osaki Yukio

Oncology Reports, Vol. 28, Iss. 3, 2012-09 ,pp. : 835-840

Spandidos Publications

Access to resources Recommend Favorite

Prognostic Significance of Survivin and Caspase-3 Immunohistochemical Expression in Patients with Diffuse Large B-cell Lymphoma Treated with Rituximab and CHOP

By Mitrović Zdravko

Pathology & Oncology Research, Vol. 17, Iss. 2, 2011-06 ,pp. : 243-247

Springer Publishing Company

Access to resources Recommend Favorite

Overexpression of DNA methyltransferase 1 as a negative independent prognostic factor in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximab

Oncology Letters, Vol. 9, Iss. 5, 2015-01 ,pp. : 2307-2312

Spandidos Publications

Access to resources Recommend Favorite

Primary diffuse large B-cell lymphoma of the dura without systemic recurrence four years after diagnosis and successful therapy

By Berget Ellen

Acta Oncologica, Vol. 52, Iss. 5, 2013-06 ,pp. : 1047-1049

Informa Healthcare

Access to resources Recommend Favorite

Clinical and prognostic significance of miR-155 and miR-146a expression levels in formalin-fixed/paraffin-embedded tissue of patients with diffuse large B-cell lymphoma

Experimental and Therapeutic Medicine, Vol. 3, Iss. 5, 2012-01 ,pp. : 763-770

Spandidos Publications

Access to resources Recommend Favorite